Brigitte R.
- Country
- Germany
- Department
- Universitaetsklinikum Ulm, Klinik für Frauenheilkunde und Geburtshilfe
Research Overview
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- Comparative Evaluation of Giredestrant and Triptorelin Versus Anastrozole and Triptorelin in Premenopausal ER-Positive/HER2-Negative Early Breast Cancer
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in High-Risk HER2-Positive Breast Cancer with Residual Disease
Data & Insights
Has run more than one trial at 161 of 477 partner sites.
Specializations
Advanced Breast Cancer Treatment
Specializes in treating hormone receptor-positive HER2-negative breast cancer, with particular focus on managing locally advanced and metastatic cases. Investigates innovative therapeutic combinations for patients with ESR1 mutations.
- Endocrine Therapy Advancement
- CDK4/6 Inhibitor Applications
- Targeted Molecular Therapies
Early-Stage Breast Cancer
Focuses on developing treatments for HER2-positive breast cancer and triple-negative breast cancer. Explores novel approaches in neoadjuvant therapy and post-surgical treatment strategies.
- Residual Disease Management
- Immunotherapy Applications
- Treatment Response Assessment
Precision Medicine Approaches
Conducts research in biomarker-driven treatment strategies and personalized therapeutic approaches. Specializes in evaluating novel compounds for specific breast cancer subtypes.
- Molecular Profiling
- Treatment Resistance Mechanisms
- Clinical Outcome Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.